|
Volumn 6, Issue 8, 2005, Pages 46-57
|
Autism and the autistic spectrum disorders
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICONVULSIVE AGENT;
ATYPICAL ANTIPSYCHOTIC AGENT;
CENTRAL STIMULANT AGENT;
CLONIDINE;
HALOPERIDOL;
HALOPERIDOL DECANOATE;
MAGNESIUM;
NEUROLEPTIC AGENT;
OMEGA 3 FATTY ACID;
OMEGA 6 FATTY ACID;
PYRIDOXINE;
RISPERIDONE;
SEROTONIN UPTAKE INHIBITOR;
THALIDOMIDE;
VALPROIC ACID;
AGITATION;
ASPERGER SYNDROME;
AUTISM;
BEHAVIOR DISORDER;
BODY WEIGHT DISORDER;
CHELATION THERAPY;
CLINICAL TRIAL;
COMMUNICATION DISORDER;
DAILY LIFE ACTIVITY;
DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS;
DIET THERAPY;
DISEASE EXACERBATION;
ENVIRONMENTAL FACTOR;
FAMILY;
GASTROINTESTINAL DISEASE;
HEREDITY;
HUMAN;
IMMUNIZATION;
INFANTILE AUTISM;
INTERPERSONAL COMMUNICATION;
LEARNING DISORDER;
OCCUPATIONAL THERAPY;
PLAY;
PLAY THERAPY;
PREGNANCY COMPLICATION;
PREVALENCE;
PROGNOSIS;
REVIEW;
SOCIAL DISABILITY;
SOCIAL INTERACTION;
SOCIAL SUPPORT;
SPEECH THERAPY;
SYSTEMATIC REVIEW;
TARDIVE DYSKINESIA;
VITAMIN SUPPLEMENTATION;
WEIGHT GAIN;
|
EID: 23844540842
PISSN: 1443430X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (0)
|